Cargando…
Patient-Reported Complications after Intravitreal Injection and Their Predictive Factors
PURPOSE: The intravitreal injection (IVI) of pharmacologic agents is the most commonly performed ocular procedure and is associated with a host of complications. Most IVI-related complications data are derived from randomized controlled clinical trials, which report a high adverse event rate. The na...
Autores principales: | Ramos, Michael S., Xu, Lucy T., Singuri, Srinidhi, Castillo Tafur, Julio C., Arepalli, Sruthi, Ehlers, Justis P., Kaiser, Peter K., Singh, Rishi P., Rachitskaya, Aleksandra V., Srivastava, Sunil K., Sears, Jonathan E., Schachat, Andrew P., Babiuch, Amy S., Sharma, Sumit, Martin, Daniel F., Lowder, Careen Y., Singh, Arun D., Yuan, Alex, Nowacki, Amy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548755/ https://www.ncbi.nlm.nih.gov/pubmed/33059077 http://dx.doi.org/10.1016/j.oret.2020.09.024 |
Ejemplares similares
-
Optical coherence tomography angiography characteristics of choroidal neovascularization requiring varied dosing frequencies in treat-and-extend management: An analysis of the AVATAR study
por: Uchida, Atsuro, et al.
Publicado: (2019) -
A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis
por: Singh, Rishi P, et al.
Publicado: (2014) -
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis
por: Singh, Rishi P, et al.
Publicado: (2015) -
Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Kaiser, Stephanie M, et al.
Publicado: (2021) -
Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis
por: Babiuch, Amy S., et al.
Publicado: (2019)